NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cmbio

Cmbio

Private
CopenhagenHealthcare & Life Scienceshttps://cmbio.io/

Last Round

VC Round

Oct 11, 2022

Total Funding Raised

$10M

Company Overview

Cmbio is a biotechnology company that provides a global multi-omics science and technology platform for microbiome and metabolomics research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Healthcare Analytics, Environmental Monitoring

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Usage-Based SaaS, Subscription SaaS, Government Contracts

AI Layer

Application

Keywords

multi-omics servicescontract research organizationCROmicrobiome servicesomics CROshotgun metagenomicsmetabolomicsbioinformatics servicesproteomicslong-read metagenomicssequencing as a serviceD2C testing enablementGxP compliantCLIA certifieddrug discovery servicesclinical trial supportagricultural microbiomedigital biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cmbio Comparables

Compare Cmbio with similar companies based on industry and business-model similarity.

Cmbio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BaseClear B.V.
78%
Mapmygenome
77%
Metabolon
74%

Cmbio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 11, 2022
Series BJan 27, 2016
Series ADec 15, 2011

Key People

Founding team and executive leadership

Anders Grøn

Chief Executive Officer

Executive Team

Mads Toft Søndergaard

Chief Technology Officer

Executive Team

Cmbio Investors

Notable investors and investment history

Cmbio investors
InvestorRounds
Applied Value GroupSeries B
Seventure PartnersVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 25, 2026

    Grew 18% QoQ, from 94 to 111 employees.

  • Apr 6, 2025

    Grew 83% QoQ, from 54 to 99 employees.

Cmbio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cmbio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cmbio's valuation, stock price, and market status.

Firmographic Details

HeadquartersCopenhagen
Employee Range122
Year Founded2015
Last FundingOct 11, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.